#injective $INJ It consolidates near USD $7.85 this September 23, 2026 after a 42% weekly gain.
Injective #INJ trades around USD $7.85 after accumulating a 42% weekly gain and doubling its usual volume, with catalysts such as the Meridian upgrade and the community buyback on the radar. The technical momentum is clearly bullish, but the RSI is in overbought territory and a possible pullback raises the key question: buy, hold, or secure profits.
Market hedging attributes a move close to 5% in 12 hours to the combination of the Meridian upgrade, the community buyback program (Community BuyBack), and the competitive narrative with Solana in decentralized trading infrastructure.
Injective is a blockchain optimized for finance: it offers native infrastructure for derivatives, spot, and prediction markets, with high-speed execution. Its monetization comes from on-chain activity and mechanisms such as community buybacks, which return value to the token and reduce the effective circulating supply.
Recommendation: HOLD, with staggered buys only on pullbacks.
Methodology: from five technical signals assessed, three favor continuation to the upside (bullish MACD, price above all relevant SMAs, 90-day Fibonacci in an uptrend), while two warn of imminent risk of a pause (RSI at 71.9 in overbought territory and stochastic at 85.6). Elevated and sustained volume, with a volume-to-market-cap ratio of 29% versus the average 13.55%, validates the move but also suggests speculative participation that can reverse quickly.
Short term: hold positions with a stop-loss at $7.50. Buy only on pullbacks at $7.55-$7.71 with targets at $8.24-$8.29 and partial profit-taking above $8.24. Reassess after any close below the SMA-5 at $7.71.
Injective is going through one of its best stretches of the year, with an 88.69% return accumulated since January 1 and a technical structure fully aligned to the upside.
Injective #INJ trades around USD $7.85 after accumulating a 42% weekly gain and doubling its usual volume, with catalysts such as the Meridian upgrade and the community buyback on the radar. The technical momentum is clearly bullish, but the RSI is in overbought territory and a possible pullback raises the key question: buy, hold, or secure profits.
Market hedging attributes a move close to 5% in 12 hours to the combination of the Meridian upgrade, the community buyback program (Community BuyBack), and the competitive narrative with Solana in decentralized trading infrastructure.
Injective is a blockchain optimized for finance: it offers native infrastructure for derivatives, spot, and prediction markets, with high-speed execution. Its monetization comes from on-chain activity and mechanisms such as community buybacks, which return value to the token and reduce the effective circulating supply.
Recommendation: HOLD, with staggered buys only on pullbacks.
Methodology: from five technical signals assessed, three favor continuation to the upside (bullish MACD, price above all relevant SMAs, 90-day Fibonacci in an uptrend), while two warn of imminent risk of a pause (RSI at 71.9 in overbought territory and stochastic at 85.6). Elevated and sustained volume, with a volume-to-market-cap ratio of 29% versus the average 13.55%, validates the move but also suggests speculative participation that can reverse quickly.
Short term: hold positions with a stop-loss at $7.50. Buy only on pullbacks at $7.55-$7.71 with targets at $8.24-$8.29 and partial profit-taking above $8.24. Reassess after any close below the SMA-5 at $7.71.
Injective is going through one of its best stretches of the year, with an 88.69% return accumulated since January 1 and a technical structure fully aligned to the upside.
